The Evaluation of Bioequivalence Between a Single-dose Pen and a Multi-dose Pen of HRS9531 Injection Solution
Clinical trial NCT06792955 · COMPLETED
Trial details
- NCT number
- NCT06792955
- Sponsor
- Fujian Shengdi Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-11
- Primary completion
- 2025-06-06
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.